Literature DB >> 8255482

Ifosfamide causes a diazepam-sensitive encephalopathy.

N A Simonian1, F G Gilliam, K H Chiappa.   

Abstract

An encephalopathy characterized by confusion, stupor, and mutism frequently occurs during administration of the chemotherapeutic drug ifosfamide (IFX). We investigated two patients who developed encephalopathy during IFX infusion. Both exhibited a rapid and near-complete restoration of baseline mental status functioning concurrent with EEG improvement after administration of intravenous diazepam. We recommend an EEG and trial of benzodiazepines in patients with IFX encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8255482     DOI: 10.1212/wnl.43.12.2700

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

Authors:  Bernd Kasper; Christoph Harter; Julia Meissner; Frauke Bellos; Fatime Krasniqi; Anthony D Ho; Gerlinde Egerer
Journal:  Support Care Cancer       Date:  2004-01-16       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.